Gene: HID1
Official Full Name: HID1 domain containingprovided by HGNC
Gene Summary: Located in Golgi apparatus; cytoplasmic microtubule; and cytosol. Implicated in developmental and epileptic encephalopathy 105. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17114 | HID1 Knockout cell line (HCT 116) | Human | HID1 | 1:2~1:4 | Negative | Online Inquiry |
KO17115 | HID1 Knockout cell line (HEK293) | Human | HID1 | 1:3~1:6 | Negative | Online Inquiry |
KO17116 | HID1 Knockout cell line (A549) | Human | HID1 | 1:3~1:4 | Negative | Online Inquiry |
HID1 Gene Knockout Cell Lines are meticulously engineered cellular models that lack the expression of the HID1 gene, a mutation often implicated in various pathological conditions. These cell lines are created through advanced gene editing technologies, notably CRISPR-Cas9 techniques, which enable precise sequence alterations, ensuring reliable and reproducible results.
The primary function of HID1 Gene Knockout Cell Lines is to serve as essential tools for elucidating the biological roles of the HID1 gene. By removing the native gene expression, researchers can investigate downstream signaling pathways, cellular interactions, and phenotypic alterations associated with gene loss. This model facilitates a deeper understanding of disease mechanisms, particularly in cancer biology and neurodegenerative disorders, where HID1 is hypothesized to play a vital role.
In terms of scientific importance, these knockouts are invaluable for both fundamental research and translational applications. In laboratory settings, they provide insights necessary for drug development, identification of potential biomarkers, and the exploration of novel therapeutic targets. Clinically, understanding the implications of HID1 knockout can lead to advancements in personalized medicine, allowing clinicians to tailor interventions based on genetic profiles.
Compared to other conventional methods, such as RNA interference or oligonucleotide-based approaches, HID1 Gene Knockout Cell Lines offer enhanced specificity and permanence in gene disruption, resulting in more stable phenotypic expressions. This permanence allows longer-term studies, giving researchers a distinct advantage in conducting thorough investigations.
For researchers and clinicians seeking robust, reliable models to advance their understanding of disease processes linked to the HID1 gene, these knockout cell lines are an essential resource. Their well-characterized nature ensures high reproducibility and reliability needed for rigorous scientific study.
Our company has a longstanding commitment to excellence in the production of high-quality biological products and is dedicated to providing cutting-edge tools that empower breakthroughs in life sciences research. With our expertise in gene editing and cell line development, we stand ready to support your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.